In the US, Methyclothiazide (methyclothiazide systemic) is a member of the drug class thiazide diuretics and is used to treat Edema and High Blood Pressure.
US matches:
- Methyclothiazide
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C03AA08
CAS registry number (Chemical Abstracts Service)
0000135-07-9
Chemical Formula
C9-H11-Cl2-N3-O4-S2
Molecular Weight
360
Therapeutic Category
Diuretic agent, benzothiadiazide
Chemical Name
2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3-(chloromethyl)-3,4-dihydro-2-methyl-, 1,1-dioxide
Foreign Names
- Methyclothiazidum (Latin)
- Methyclothiazid (German)
- Méthyclothiazide (French)
- Meticlotiazida (Spanish)
Generic Names
- Methyclothiazide (OS: BAN, USAN, JAN)
- Méthyclothiazide (OS: DCF)
- Meticlotiazide (OS: DCIT)
- Methyclothiazide (PH: USP 32)
Brand Names
- Enduron
Abbott, United States - Isobar (Methyclothiazide and Triamterene)
Chiesi, France; Chiesi, Tunisia; IBN, Tunisia - Methyclothiazide
Mylan, United States; Sandoz, United States; Watson, United States
International Drug Name Search
Glossary
BAN | British Approved Name |
DCF | Dénomination Commune Française |
DCIT | Denominazione Comune Italiana |
JAN | Japanese Accepted Name |
OS | Official Synonym |
PH | Pharmacopoeia Name |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment